REVELAR BIOTHERAPEUTICS, INC.

Profile

Company Names

REVELAR BIOTHERAPEUTICS, INC.

Addresses

9630 EAGLE RIDGE DRIVE, BETHESDA, MD 20817

Phone Numbers

(301) 291-5113

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$18,500,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-02-04 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
1
2021-11-01 
$17,500,000.00 
$22,500,000.00 
$5,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
FONTEYNE 
DIRECTOR
DALCOR PHARMACEUTICALS US, LLC   |  ALLYX THERAPEUTICS, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  GELESIS HOLDINGS, INC.   |  APNIMED, INC.   |  TRITON THERAPEUTICS, INC.
BRETT 
 
GIROIR 
DIRECTOR
REVELAR BIOTHERAPEUTICS, INC.   |  ALTESA BIOSCIENCES, INC.   |  ONCONANO MEDICINE, INC.
GLENN 
 
MARINA 
EXECUTIVE OFFICER, DIRECTOR
REVELAR BIOTHERAPEUTICS, INC.
DAVID 
 
SCHEER 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  TENGION INC   |  PLANIT IMPACT INC.   |  DNAMX, INC.   |  REFACTOR HEALTH, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  ADELA, INC.   |  THIRDLAW MOLECULAR, INC.
LAURENCE 
 
SMITH 
EXECUTIVE OFFICER
MOD SYSTEMS INC   |  REVELAR BIOTHERAPEUTICS, INC.   |  FIRST EAGLE PRIVATE CREDIT FUND
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-02-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-04 
2021-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#